Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1050 of 5804
-
Could a seizure drug also prevent sudden death in dravet syndrome?
Disease control Recruiting nowThis study investigates cerebrovascular reactivity (CVR) and functional brain connectivity in Dravet Syndrome (DS) patients with convulsive seizures. Using functional MRI (fMRI), we will define differences in brain responses to CO₂ changes before administration of the drug Fintep…
Phase: PHASE4 • Sponsor: The University of Texas Health Science Center, Houston • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
New eye implant shows promise for Long-Term wet AMD control
Disease control Recruiting nowStudy to Evaluate Long-Term Safety of Intravitreal OTX-TKI (Axitinib Implant) in Participants with Neovascular Age-Related Macular Degeneration Who Successfully Completed 2-Year OTX-TKI-2023-AMD-301 or OTX-TKI-2023-AMD-303 Study
Phase: PHASE3 • Sponsor: Ocular Therapeutix, Inc. • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New PET scan agent aims to sharply detect multiple cancers
Diagnosis Recruiting nowThe goal of this clinical trial is to evaluate the diagnostic value of CAIX protein specific probe 18F-T2 in PET/CT imaging in participants with solid tumors. It will also assess the safety, tolerability and radiation dosimetry of 18F-T2.
Phase: NA • Sponsor: Peking University First Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 12:33 UTC
-
Could a multiple sclerosis drug help save insulin cells in type 1 diabetes?
Disease control Recruiting nowThis is a non-randomized, parallel-controlled, single-center, open-label clinical trial designed to evaluate the efficacy of dimethyl fumarate in preserving pancreatic beta-cell function in adults with type 1 diabetes, as well as its safety and tolerability in this population. E…
Phase: PHASE2, PHASE3 • Sponsor: Nanjing Medical University • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
New drug BC006 aims to slow lung scarring in IPF patients
Disease control Recruiting nowThis is a multicenter, Phase II clinical study to evaluate the efficacy and safety of BC006 over a 24-week treatment period in patients with idiopathic pulmonary fibrosis (IPF). The study consists of two phases: an open-label safety run-in phase and a double-blind, randomized, pl…
Phase: PHASE2 • Sponsor: Dragonboat Biopharmaceutical Company Limited • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New drug combo before prostate surgery shows promise in early trial
Disease control Recruiting nowResearchers are looking for a better way to treat men who have high-risk localized prostate cancer, which refers to a type of prostate cancer that is still confined to the prostate gland but has certain characteristics that make it more likely to grow and spread. The study treat…
Phase: PHASE2 • Sponsor: Bayer • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New hope for advanced colon cancer patients who've run out of options
Disease control Not yet recruitingTo evaluate the safety and efficacy of SHR-3821 combined with fruquintinib in the advanced colorectal cancer after failure of standard therapy
Phase: PHASE2 • Sponsor: Meng Qiu • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Custom 3D-Printed titanium implants could rebuild faces after injury or surgery
Disease control Recruiting nowThis clinical study aims to evaluate the effectiveness of patient-specific 3D-printed titanium facial implants in the reconstruction and aesthetic correction of facial defects. The study will include patients presenting with congenital, traumatic, or post-surgical facial deformit…
Phase: NA • Sponsor: Tishreen University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could ultrasound replace X-Rays in heart valve surgery?
Disease control Not yet recruitingAortic stenosis (AS) is a common valvular heart disease whose prevalence increases markedly with age-approximately 2-4% in individuals aged 65 years and older, and up to 3.4% for severe AS in those over 75. Degenerative calcific AS predominates in high-income countries, whereas r…
Phase: PHASE4 • Sponsor: China National Center for Cardiovascular Diseases • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New drug could scratch the itch for dialysis patients
Symptom relief Not yet recruitingA randomized, placebo-controlled, double-blind trial will be conducted in the Department of Nephrology at Chittagong Medical College Hospital, Chattogram, Bangladesh, over a period of one and a half years. A total of 102 patients with chronic kidney disease (CKD) undergoing maint…
Phase: NA • Sponsor: Chittagong Medical College • Aim: Symptom relief
Last updated Jun 27, 2026 12:06 UTC
-
New oxygen method may speed recovery from High-Altitude lung condition
Symptom relief Recruiting nowThis study aims to evaluate whether High-flow Nasal Cannula Oxygen Therapy (HFNC) provides superior respiratory support compared to Conventional Oxygen Therapy (COT) in patients with High-Altitude Pulmonary Edema (HAPE).
Phase: NA • Sponsor: Third Military Medical University • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Video game therapy: wii fit may boost balance in kids with cerebral palsy
Symptom relief Not yet recruitingThe goal of this clinical trial is to determine whether virtual reality (VR) training using the Nintendo Wii Fit can improve balance, gross motor function, and agility in children aged 7-14 years with spastic cerebral palsy (GMFCS Levels I-II). The main questions it aims to answe…
Phase: NA • Sponsor: Ziauddin University • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
New cholesterol drug artisterol put to the test in global trial
Disease control Recruiting nowThe goal of this clinical trial is to learn if Artisterol works to lower LDL cholesterol and other metabolic and vascular risk factors in adults. The main questions it aims to answer are: • Does Artisterol lower low-density lipoprotein cholesterol (LDL-C) levels in participants …
Phase: NA • Sponsor: Zentiva, k.s. • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New hope for stubborn eczema? abrocitinib tested after biologics fail
Disease control Recruiting nowThis is a prospective, multi-center observational study characterizing clinical and patient reported outcomes of patients receiving abrocitinib for moderate-to-severe atopic dermatitis (M2S AD) who had inadequate response (or intolerance) to ≤2 previous biologic therapies approve…
Sponsor: Pfizer • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Could a headset at home lift bipolar depression?
Symptom relief Recruiting nowBipolar depression is a long-lasting and disabling condition, and many people continue to experience depressive symptoms despite standard treatments. Transcranial direct current stimulation (tDCS) is a non-invasive form of brain stimulation that uses a very small electrical curre…
Phase: NA • Sponsor: King's College London • Aim: Symptom relief
Last updated Jun 27, 2026 12:25 UTC
-
Diabetes drug semaglutide may speed healing of foot sores
Disease control Recruiting nowThe aim of this exploratory pilot study is to investigate the effect of semaglutide compared to placebo on healing of foot ulcers in type 2 diabetes patients. It is a randomized double blind, placebo controlled, clinical intervention study of 20 weeks intervention.
Phase: PHASE3 • Sponsor: Ole Lander Svendsen • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New pill could help when steroids fail for bulging eyes
Disease control Recruiting nowThyroid Eye Disease (TED), also known as Graves' orbitopathy, is an autoimmune condition that causes inflammation and tissue expansion behind the eyes, leading to bulging eyes (proptosis), double vision, and pain. Currently, intravenous glucocorticoids (steroids) are the standard…
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Xiamen University • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New PET tracer could slash unnecessary biopsies for head and neck cancer patients
Diagnosis Recruiting nowThis Phase I, single-institution, open-label study will evaluate the safety, tolerability, and diagnostic performance of \[18F\]NOTA-ABY030 PET/CT in patients with head and neck squamous cell carcinoma (HNSCC) who present with indeterminate lesions on standard imaging. The invest…
Phase: PHASE1 • Sponsor: Vanderbilt-Ingram Cancer Center • Aim: Diagnosis
Last updated Jun 27, 2026 12:32 UTC
-
New drug aims to shrink nasal polyps without surgery
Disease control Recruiting nowThis is a multicentre, open-label, single-arm, Phase 3b study to assess nasal polyps score and symptoms in Chinese adult participants with chronic rhinosinusitis with nasal polyposis initiating treatment with tezepelumab.
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Heart risk after pregnancy: coaching plus monitoring shows promise
Disease control Recruiting nowThe goal of this clinical trial is to find out whether an enhanced program works better than remote blood pressure monitoring (RBPM) alone for women who had high blood pressure during pregnancy. The enhanced program combines RBPM with a lifestyle program led by a community health…
Phase: NA • Sponsor: University of South Carolina • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC